Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England.

Howell-Jones R, Bailey A, Beddows S, Sargent A, de Silva N, Wilson G, Anton J, Nichols T, Soldan K, Kitchener H; Study Group Collaborators..

Br J Cancer. 2010 Jul 13;103(2):209-16. doi: 10.1038/sj.bjc.6605747. Erratum in: Br J Cancer. 2010 Sep 7;103(6):928.

2.

Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.

Simonella LM, Lewis H, Smith M, Neal H, Bromhead C, Canfell K.

BMC Infect Dis. 2013 Mar 3;13:114. doi: 10.1186/1471-2334-13-114.

3.

Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.

Coutlée F, Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, Ghatage P, Koushik A, Ferenczy A, Franco EL.

J Med Virol. 2011 Jun;83(6):1034-41. doi: 10.1002/jmv.22081.

PMID:
21503917
4.

Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.

Sánchez-Lander J, Cortiñas P, Loureiro CL, Pujol FH, Medina F, Capote-Negrín L, Bianchi G, García-Barriola V, Ruiz-Benni A, Avilán-Rovira J, Acosta H.

Cancer Epidemiol. 2012 Oct;36(5):e284-7. doi: 10.1016/j.canep.2012.04.005. Epub 2012 May 17.

PMID:
22608058
5.

Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy.

Carozzi FM, Tornesello ML, Burroni E, Loquercio G, Carillo G, Angeloni C, Scalisi A, Macis R, Chini F, Buonaguro FM, Giorgi Rossi P; HPV Prevalence Italian Working Group..

Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2389-400. doi: 10.1158/1055-9965.EPI-10-0131.

6.

Assessment of HPV DNA test value in management women with cytological findings of ASC-US, CIN1 and CIN2.

Pajtler M, Milicić-Juhas V, Milojković M, Topolovec Z, Curzik D, Mihaljević I.

Coll Antropol. 2010 Mar;34(1):81-6.

PMID:
20432737
7.

[A comparison of human papillomavirus detection and ThinPrep cytology test for women in Guangdong province].

Xue YH, Chen ZX, Zheng BW, Zhang JM, Zhu QY.

Zhonghua Zhong Liu Za Zhi. 2005 May;27(5):283-5. Chinese.

PMID:
15996320
8.

Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.

Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S.

Coll Antropol. 2010 Mar;34(1):19-24.

PMID:
20432728
9.

Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.

Einstein MH, Martens MG, Garcia FA, Ferris DG, Mitchell AL, Day SP, Olson MC.

Gynecol Oncol. 2010 Aug 1;118(2):116-22. doi: 10.1016/j.ygyno.2010.04.013. Epub 2010 May 21.

PMID:
20488510
10.

HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: A population-based study from Northern Ireland.

Anderson LA, O'Rorke MA, Wilson R, Jamison J, Gavin AT; Northern Ireland HPV Working Group..

J Med Virol. 2016 Jul;88(7):1262-70. doi: 10.1002/jmv.24447. Epub 2016 Jan 5.

PMID:
26680281
11.

[Investigation of human papillomavirus, its types and variants].

Gudleviciene Z, Didziapetriene J, Suziedelis K, Lapkauskaite L.

Medicina (Kaunas). 2005;41(11):910-5. Lithuanian.

12.

Prevalence of human papillomavirus types 16, 18, and 45 in women with cervical intraepithelial changes: associations with colposcopic and histological findings.

Jarienė K, Vaitkienė D, Bartusevičius A, Tvarijonavičienė E, Minkauskienė M, Nadišauskienė R, Kruminis V, Kliučinskas M.

Medicina (Kaunas). 2012;48(1):22-30.

13.

Prevalence of human papillomavirus infection among women with and without normal cervical histology in Shandong Province, China.

Yuan X, Yang Y, Gu D, Liu H, Yang H, Wang M.

Arch Gynecol Obstet. 2011 Jun;283(6):1385-9. doi: 10.1007/s00404-010-1584-0. Epub 2010 Jul 14.

PMID:
20628750
14.

Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.

Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.

BJOG. 2006 Nov;113(11):1303-7. Epub 2006 Sep 15.

15.

Prevalence and type distribution of human papillomavirus in healthy Japanese women aged 20 to 25 years old enrolled in a clinical study.

Konno R, Tamura S, Dobbelaere K, Yoshikawa H.

Cancer Sci. 2011 Apr;102(4):877-82. doi: 10.1111/j.1349-7006.2011.01878.x. Epub 2011 Feb 17.

16.

Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Fiji.

Tabrizi SN, Law I, Buadromo E, Stevens MP, Fong J, Samuela J, Patel M, Mulholland EK, Russell FM, Garland SM.

Sex Health. 2011 Sep;8(3):338-42. doi: 10.1071/SH10083.

PMID:
21851773
18.

[Study on the distribution of human papillomavirus types in cervix among Chinese women: a meta-analysis].

Bao YP, Li N, Wang H, Qiao YL.

Zhonghua Liu Xing Bing Xue Za Zhi. 2007 Oct;28(10):941-6. Chinese.

PMID:
18399135
19.

Correlation of human papilloma virus infection with cytology, colposcopy and histopathological examination of the bioptic tissue in low- and high-grade intraepithelial lesions.

Jovanović AM, Dikic SD, Jovanovic V, Zamurovic M, Nikolic B, Krsic V, Rakic S, Stanimirovic B.

Eur J Gynaecol Oncol. 2012;33(5):512-6.

PMID:
23185799
20.

Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.

Monsonego J, Zerat L, Syrjänen K, Zerat JC, Smith JS, Halfon P.

Vaccine. 2012 Jul 27;30(35):5215-21. doi: 10.1016/j.vaccine.2012.06.013. Epub 2012 Jun 17.

PMID:
22713720

Supplemental Content

Support Center